35081 |
Otorhinolaryngology; Surgery |
Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases wi... |
HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067 |
고영혜 |
2020 |
35080 |
Pathology |
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and... |
MODERN PATHOL 2020 10.1038/s41379-019-0392-8 |
고영혜 |
2020 |
35079 |
Hematology |
Survival outcomes of patients with extranodal natural-killer T-cell ly... |
Lancet Haematol 2020 10.1016/S2352-3026(19)30283-2 |
고영혜 |
2020 |
35078 |
Medicine, General & Internal |
Successful Sirolimus Treatment for Korean Patients with Activated Phos... |
YONSEI MED J 2020 10.3349/ymj.2020.61.6.542 |
고영혜 |
2020 |
35077 |
Oncology |
Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients... |
BMC CANCER 2020 10.1186/s12885-020-6612-2 |
고영혜 |
2020 |
35076 |
Hematology |
Progression of AITL-like tumors in mice is driven by Tfh signature pro... |
BLOOD ADV 2020 10.1182/bloodadvances.2019001114 |
고영혜 |
2020 |
35075 |
Oncology |
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Ex... |
CANCER RES TREAT 2020 10.4143/crt.2019.198 |
고영혜 |
2020 |
35074 |
Biochemistry & Molecular Biology; Cell Biology; Immunology |
Pre-treatment serum IL-10 predicts the risk of secondary central nervo... |
CYTOKINE 2020 10.1016/j.cyto.2020.155048 |
고영혜 |
2020 |
35073 |
Hematology |
A phase II study of ibrutinib in combination with rituximab-cyclophosp... |
ANN HEMATOL 2020 10.1007/s00277-020-04005-6 |
고영혜 |
2020 |
35072 |
Hematology |
A comprehensive analysis of adult patients with secondary hemophagocyt... |
ANN HEMATOL 2020 10.1007/s00277-020-04083-6 |
고영혜 |
2020 |